Supporting this notion, acceleration of Aβ aggregation was observed in an AD mouse model given an anti-TTR antibody and in mice in which the endogenous Ttr gene was silenced by targeted interruption, while overexpression of WT human TTR inhibited the pathologic and behavioral changes usually seen in these mice (Li et al., 2011). Here, TTR is linked to Alzheimer disease.